The Competent Authority for medical devices in Taiwan TFDA has extended the transition period for the application of the new „Technical Cooperation Programme“ for an abbreviated market access to Taiwan until 31 December 2021.
Clients of mdc can also benefit from this due to the fact that we were already recognized under TCP II and are in an advanced stage of recognition under TCP III.
You can find the relevant publication of TFDA and the list of Notified Bodies concerned here.
